CClinicalTrials.gg
RecruitingNCT07215507Updated Jan 29, 2026

Timing of Physician Rounds for Antepartum Patients

An interventional study of Discovery Rounding and Standard Rounding in Physician Rounds and Communication, sponsored by Duke University. Recruiting at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Duke University · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Currently, two rounding methods are used interchangeably for patients who do not have pregnancy or delivery complications that would preclude participation in delayed daytime rounding. This randomized controlled trial will compare two rounding models: the standard model, in which patients receive two rounds (an early morning bedside encounter and a later team discussion), and the intervention model, which consolidates both rounds into a single, later-morning bedside encounter following the team's review of clinical data. The primary objective is to assess whether consolidating physician rounds into a single, later-morning encounter-referred to as discovery rounding-improves patient satisfaction with communication.

02

Conditions studied

  • Physician Rounds
  • Communication

Browse trials for

03

In context

Communication

183 studies on the registry are indexed under Communication; 87 are open to participants now.

This study's planned enrollment of 200 is above the median of 171 across 158 interventional studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pregnant women greater than 20 weeks gestation admitted to the antepartum list at Duke University Hospital

Exclusion criteria

Exclusion Criteria:

  • Stillbirth
  • ICU admission
  • Admission to off-service unit
  • Active magnesium sulfate administration
  • Active severe hypertension or initiation of anti-hypertensive pathway within past 8 hours
  • Category II fetal heart rate tracing
  • Other pregnancy/delivery complication precluding delayed rounding
  • Unstable/unsuitable condition per overnight team or attending physician
  • Previously enrolled/on active board >1 day at morning rounds
  • Postpartum readmission
  • Antepartum admission within the last 4 weeks
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Standard Rounding

    The current standard of rounding on the Antepartum service involves a preliminarily bedside encounter with patients between 5-7am by a resident +/- medical student before an attending physician-led Antepartum team discussion from 8-9am. The patient is then rounded on for a second time in the late morning by the entire Antepartum team where patient concerns are heard and care plans for the day are relayed/reiterated/cemented.

    Behavioral: Standard Rounding

  • Experimental
    Discovery Rounding

    For certain patients with appropriate clinical risk factors, our service has adopted a policy of "discovery rounding". This method involves solely electronic health record chart review prior to the 8am attending-led Antepartum team discussion where the patient's overnight events are "discovered", clinical courses discussed, and daytime plans proposed. "Discovery rounding" consolidates bedside physician-patient encounters to one mid-morning interaction, forgoing early morning disturbances.

    Behavioral: Discovery Rounding

Interventions

  • BehavioralDiscovery Rounding

    For certain patients with appropriate clinical risk factors, our service has adopted a policy of "discovery rounding". This method involves solely electronic health record chart review prior to the 8am attending-led Antepartum team discussion where the patient's overnight events are "discovered", clinical courses discussed, and daytime plans proposed. "Discovery rounding" consolidates bedside physician-patient encounters to one mid-morning interaction, forgoing early morning disturbances.

  • BehavioralStandard Rounding

    The current standard of rounding on the Antepartum service involves a preliminarily bedside encounter with patients between 5-7am by a resident +/- medical student before an attending physician-led Antepartum team discussion from 8-9am. The patient is then rounded on for a second time in the late morning by the entire Antepartum team where patient concerns are heard and care plans for the day are relayed/reiterated/cemented.

06

What researchers measure

Primary outcomes

  1. Proportion of items rated as "Excellent" on the Communication Assessment Tool (CAT)

    The CAT measures patients' perceptions of physician communication across 15 specific behaviors, such as listening carefully, showing respect, explaining information clearly, and spending sufficient time with the patient. Each item is rated on a 5-point Likert scale ranging from "Poor" to "Excellent." By focusing on the frequency of "Excellent" ratings, the CAT provides a robust, patient-centered measure of the effectiveness and impact of physician communication during hospitalization.

    Time frame: One of the following timepoints (whichever comes first for that patient); Hospital day 6 or the immediate postpartum period: postpartum day 0 or 1, depending on the time of delivery

Secondary outcomes

  1. Edinburgh Postnatal Depression Scale (EPDS)

    A 10-item self-report questionnaire, validated for both postpartum and antepartum use, in which each item is scored 0-3 (total 0-30), with higher scores indicating greater depressive symptoms and a common cut-off of ≥13 suggesting possible clinical depression.

    Time frame: At the 6 week postpartum visit

07

Study locations

1 of 2 sites recruiting
  • Duke University Hospital
    Durham, North Carolina 27710, United States
    Not yet recruiting
  • Duke University Hospital
    Durham, North Carolina 27710, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07215507
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Oct 10, 2025
Start date
Nov 4, 2025
Primary completion
Jan 30, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Jan 29, 2026

Study contacts

Hannah Kelly, MD
Contact
hannah.kelly@duke.edu
832-967-7998
Rachel Wood, MD
Contact
rachel.wood@duke.edu
Hannah Kelly, MD
study director · Duke University Hospital
Rachel Wood, MD
principal investigator · Duke University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion